AUG 31, 2016 09:21 AM PDT

Small Molecules Could be a way to Stop Ebola

WRITTEN BY: Carmen Leitch
3 6 359
New research published in Bioorganic & Medicinal Chemistry Letters demonstrates the ability of small molecules to block a protein that aids the spread of Ebola. While still in the early phase of development, these compounds could one day be used during an outbreak to halt the dissemination of the disease as well as to treat infected patients.
 


The devastating outbreak of Ebola virus disease (EVD) between 2013 and 2016 in West Africa caused the death of over 11,000 people. A clip from the New York Times, above, is a report about the crisis from September 2014. Attention was drawn once again to the virus, and efforts to develop resources to combat it began with urgency. While there are vaccines in development, they are protective and only work to keep a person from getting Ebola; as such they leave people vulnerable to other hemorraghic viruses.

These new compounds would not be dangerous to host cells. Instead it would work on the replication machinery of the virus.

Viruses take over the cellular machinery of the host for its own purposes. The host cells replicate the virus, and viral particles are subsequently released from the cell which leads to the infection of more cells.

The compounds target the association of the virus with the host cells, and prevent the newly produced Ebola viruses from exiting the cell; all that happens without toxicity to the host.

"Positive results showing potent viral inhibition without toxicity to normal healthy cells may lead to a paradigm shift in the search for better antiviral drugs,” explained Dr. Harty of the University of Pennsylvania School of Veterinary Medicine, one co-author of the study. “Importantly, as these virus-host interactions represent a common mechanism used by a range of RNA viruses, we predict that this virus-host interaction may represent an Achilles' heel in the life cycle of RNA viruses."

The mechanism that the virus uses to escape cells is similar to many other RNA viruses such as Lassa fever and Marburg virus. The model of the virus-host interactions that was used is between the VP40 protein of Ebola and NEDD4, a host protein. 4.8 million compounds were screened in silico to identify one that prevented VP40-NEDD4 interactions, thus preventing virus escape.
The Ebola virus, from Wikipedia Commons
 
 Harty’s team collaborated with Dr. Jay Wrobel of Fox Chase Chemical Diversity Center to analyze some commercial compounds. That led to the identification of even more potent molecules. Taking it a step further, new compounds were made to optimize efficacy. Thus, a new class of molecule targeting filovirus egress was created.

"We postulate that emergency administration of such an antiviral therapeutics during an outbreak would inhibit virus dissemination and spread in infected individuals, thus slowing disease progression and allowing the immune system more time to mount a robust response to effectively combat and clear the infection,” explained Wrobel.

The team hopes to continue work on finding the best molecule, which would then be tested on viruses. If that shows success, the testing would move to animal models before clinical trials. "This work is exciting to me since it may translate our basic science work into a potential product or therapeutic," Dr. Harty concluded.

Sources: AAAS/Eurekalert! via Elsevier, Bioorganic & Medicinal Chemistry Letters
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAY 22, 2018
Cancer
MAY 22, 2018
Breakthrough Analysis Outlines Conceivable Cause of Childhood ALL
A team from the Institute of Cancer Research has published a comprehensive literature review and outlined a breakthrough in the causative theory of childhood ALL development.
JUN 21, 2018
Videos
JUN 21, 2018
The Salmonella Bacterium
Two recent outbreaks of illness were caused by food that was contaminated with Salmonella bacteria.
JUN 30, 2018
Videos
JUN 30, 2018
First US Case of Bubonic Plague in 26 Years is Reported
It's not known exactly where the patient contracted the disease, but it was either Idaho or Oregon.
JUL 04, 2018
Drug Discovery
JUL 04, 2018
Increased Dose of Drug 'Rifampin' Effective in Eliminating Tuberculosis Bacterium
According to a randomized controlled trial, a TB drug by the name ‘Rifampin’ was seen to effectively kill TB bacteria in sputum cultures when a
JUL 17, 2018
Videos
JUL 17, 2018
Novartis Ends Antibiotic Research
The United Nations has warned that by 2050, antibiotic-resistant microbes might kill ten million people every year.
AUG 02, 2018
Genetics & Genomics
AUG 02, 2018
The Genetic Hotspots That Can Lead to Cancer
In some of our body's tissues, cells have to replicate many times. That introduces a chance for new genetic errors every time.
Loading Comments...